Community Symposium on the Molecular Basis of ME/CFS - 2017
The Community Symposium on the Molecular Basis of ME/CFS - 2017 at Stanford University was sponsored by the Open Medicine Foundation (OMF) on Saturday, August 12, 2017. The symposium was live-streamed to allow for wide patient attendance.
Speakers[edit | edit source]
- Linda Tannenbaum, CEO, OMF - Welcome
- Ashley Haugen, Event Organizer - Symposium Logistics
- Ronald W. Davis, PhD, Stanford University - Opening Remarks
- Robert K. Naviaux, MD, PhD, University of California, San Diego - Keynote Speech: The metabolism of the cell danger response, healing, and ME/CFS (in English with Spanish subtitles)
- Chris Armstrong, University of Melbourne - ME, metabolism and I (in English with Spanish subtitles)
- Jonas Bergquist, MD, PhD, Uppsala University - In search of biomarkers revealing pathophysiology in a Swedish ME/CFS patient cohort
- Maureen Hanson, PhD, Cornell University - Probing metabolism in ME/CFS
- Neil McGregor, MDSc, PhD, University of Melbourne - Genome-wide analysis & metabolome changes in ME/CFS
- Alan Light, PhD, University of Utah - Gene variants, mitochondria & autoimmunity in ME/CFS
- Baldomero Olivera, PhD, Howard Hughes Medical Institute and University of Utah - A novel source of drugs: the biodiversity of oceans
- Mario Capecchi, PhD, Nobel Laureate, University of Utah - The role of microglia in neuropsychiatric disorders
- Mark Davis, PhD, Howard Hughes Medical Institute and Stanford University - Is CFS/ME an autoimmune disease?
- Alain Moreau, PhD, University of Montreal - New research strategies for decoding ME/CFS to improve diagnosis and treatment
- Wenzhong Xiao, PhD, Massachusetts General Hospital and Harvard Medical School - Big data analysis of patient studies of ME/CFS
- Ronald W. Davis, Stanford University - Establishing new mechanistic and diagnostic paradigms for ME/CFS
- Linda Tannenbaum, OMF, CEO and Ronald W. Davis, Stanford University - Closing Remarks
Question and answer panel[edit | edit source]
Two question and answer panels were presented.
- The first panel was comprised of Drs Jonas Bergquist, Alan Light, Robert Naviaux, Maureen Hanson, Neil McGregor, and Christopher Armstrong.
- The second panel was comprised of Drs Wenzhong Xiao, Mark Davis, Ron Davis, Baldomero Olivera, Alain Moreau, and Mario Capecchi
Events handsouts[edit | edit source]
Recordings[edit | edit source]
See also[edit | edit source]
- Second Annual Community Symposium on the Molecular Basis of ME/CFS - 2018
- Third Annual Community Symposium on the Molecular Basis of ME/CFS - 2019
Learn more[edit | edit source]
- Symposium report by Raeka Aiyar, Ph.D. on storify
- "At symposium, researchers and patients examine molecular basis of chronic fatigue syndrome" by Raeka Aiyar in Scope
References[edit | edit source]
Myalgic encephalomyelitis or chronic fatigue syndrome, often used when both illnesses are considered the same.